Editorial: Insights into Neurogenetic Research Reviews
-
By
-
Lucia F. Cardo
-
September 14, 2026
Clinical Scorecard: Editorial: Insights into Neurogenetic Research Reviews
At a Glance
| Category | Detail |
|---|---|
| Condition | Neurogenetic Disorders |
| Key Mechanisms | Genetic bases and therapeutic approaches including gene therapies and RNA-based therapeutics. |
| Target Population | Individuals affected by neurogenetic disorders such as Dementia, Ataxia, Charcot-Marie-Tooth, and PRUNE1 syndrome. |
| Care Setting | Research and clinical settings focusing on neurogenetics. |
Key Highlights
- Substantial growth in clinical trials for Charcot-Marie-Tooth disorders from 1999 to 2022.
- Emerging gene therapy approaches show promise for neurogenetic disorders.
- Neuroimaging findings in PRUNE1 syndrome may aid in diagnosis and prognosis.
- Cerebrotendinous xanthomatosis is linked to CYP27A1 gene variants.
- Integration of genetic investigations and neuroimaging could enhance treatment strategies.
Guideline-Based Recommendations
Diagnosis
- Utilize clinical, radiological, and genetic information for optimal characterization of neurogenetic disorders.
Management
- Consider procedural and targeted gene therapy approaches in treatment plans.
Monitoring & Follow-up
- Regular follow-up on clinical and genetic developments in affected individuals.
Risks
- Potential complications related to genetic variants and therapeutic interventions.
Patient & Prescribing Data
Patients with neurogenetic disorders including but not limited to Charcot-Marie-Tooth, PRUNE1 syndrome, and cerebrotendinous xanthomatosis.
Gene therapies and RNA-based therapeutics are emerging as key treatment strategies.
Clinical Best Practices
- Incorporate genetic testing in the diagnostic process for neurogenetic disorders.
- Engage in multidisciplinary approaches combining genetics, imaging, and clinical assessments.
Related Resources & Content
Based on findings from:
Editorial: Reviews in neurogenetics
Lucia F. Cardo. Frontiers In Neurology, 2026.
https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1979264/full
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
